|
|
J Clin Invest. 1969 December; 48(12): 2251–2259. doi: 10.1172/JCI106191. | PMCID: PMC297482 |
Congenital dysprothrombinemia: an inherited structural disorder of human prothrombin Sandor S. Shapiro, Jose Martinez, and Ruth R. Holburn 1Cardeza Foundation for Hematologic Research, Department of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania 19107 Abstract A large family has been studied, 11 of whose members have half-normal plasma concentrations of biological prothrombin activity. The pattern of inheritance is autosomal. By use of a specific immunoassay, affected family members have been shown to possess normal quantities of immunoreactive prothrombin, whose immunologic properties seem identical with those of the normal zymogen. Prothrombin isolation from the plasma of one such individual gave normal yields of protein but half-normal amounts of prothrombin activity. Activation of this material in the “intrinsic” and “extrinsic” systems, in concentrated sodium citrate, or by trypsin, gives rise to half, or less, of the thrombin clotting and esterase activities expected from a comparable normal prothrombin preparation. During the clotting of blood from an affected individual, all material with the mobility of prothrombin disappears. Immunoelectrophoresis of the serum reveals a normal nonthrombin “pro piece,” and an additional activation product with an electrophoretic mobility intermediate between that of prothrombin and of “pro piece.” These results suggest that affected individuals are heterozygotes in whom half the prothrombin molecules synthesized are structurally abnormal, since they undergo some alterations during activation, but are incapable of releasing the active enzyme, thrombin. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. Images in this article Click on the image to see a larger version. These references are in PubMed. This may not be the complete list of references from this article. - LANCHANTIN GF, FRIEDMANN JA, DEGROOT J, MEHL JW. Preparation of human plasma prothrombin and some of its sedimentation properties. J Biol Chem. 1963 Jan;238:238–243. [PubMed]
- Aronson DL, Ménaché D. Chromatographic analysis of the activation of human prothrombin with human thrombokinase. Biochemistry. 1966 Aug;5(8):2635–2640. [PubMed]
- BARNHART MI, ANDERSON GF, BAKER WJ. Immunochemical studies on proteins important in blood coagulation. Thromb Diath Haemorrh. 1962 Oct 1;8:21–36. [PubMed]
- Josso F, Lavergne JM, Weilland C, Soulier JP. Etude immunologique de la prothrombine et de la thrombine humaines. Thromb Diath Haemorrh. 1967 Dec 31;18(3-4):311–324. [PubMed]
- Shapiro SS. Human prothrombin activation. Science. 1968 Oct 4;162(849):127–129. [PubMed]
- Ganrot PO, Niléhn JE. Immunochemical determination of human prothrombin. Scand J Clin Lab Invest. 1968;21(3):238–244. [PubMed]
- QUICK AJ, PISCIOTTA AV, HUSSEY CV. Congenital hypoprothrombinemic states. AMA Arch Intern Med. 1955 Jan;95(1):2–14. [PubMed]
- QUICK AJ, HUSSEY CV. Hereditary hypoprothrombinaemias. Lancet. 1962 Jan 27;1(7222):173–177. [PubMed]
- Lanchantin GF, Hart DW, Friedmann JA, Saavedra NV, Mehl JW. Amino acid composition of human plasma prothrombin. J Biol Chem. 1968 Oct 25;243(20):5479–5485. [PubMed]
- ELLIS BC, STRANSKY A. A quick and accurate method for the determination of fibronogen in plasma. J Lab Clin Med. 1961 Sep;58:477–488. [PubMed]
- WOLF P. A modification for routine laboratory use of Stefanini's method of estimating factor V activity in human oxalated plasma. J Clin Pathol. 1953 Feb;6(1):34–38. [PubMed]
- Shapiro SS. The immunologic character of acquired inhibitors of antihemophilic globulin (factor 8) and the kinetics of their interaction with factor 8. J Clin Invest. 1967 Feb;46(2):147–156. [PubMed]
- SEEGERS WH, McCLAUGHRY RI, FAHEY JL. Some properties of purified prothrombin and its activation with sodium citrate. Blood. 1950 May;5(5):421–433. [PubMed]
- MILLER KD. Chromatographic isolation of plasma prothrombin and t trans-alpha-glucosylase. J Biol Chem. 1958 Apr;231(2):987–995. [PubMed]
- EHRENPREIS S, SCHERAGA HA. Observations on the analysis for thrombin and the inactivation of fibrin monomer. J Biol Chem. 1957 Aug;227(2):1043–1061. [PubMed]
- SCHULTZE HE, SCHWICK G. Uber den Mechanismus der Thrombinbildung im isolierten System. Hoppe Seylers Z Physiol Chem. 1951;289(1):26–43. [PubMed]
- Shapiro SS, Martinez J. Human prothrombin metabolism in normal man and in hypocoagulable subjects. J Clin Invest. 1969 Jul;48(7):1292–1298. [PubMed]
- SCHEIDEGGER JJ. Une micro-méthode de l'immuno-electrophorèse. Int Arch Allergy Appl Immunol. 1955;7(2):103–110. [PubMed]
- Arnon R, Shapira E. Antibodies to papain. A selective fractionation according to inhibitory capacity. Biochemistry. 1967 Dec;6(12):3942–3950. [PubMed]
- Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966 Apr;15(1):45–52. [PubMed]
- DAY HJ, ZARAFONETIS CJ. Coagulation studies in four patients with Ehlers-Danlos syndrome. Am J Med Sci. 1961 Nov;242:565–573. [PubMed]
- Ganrot PO, Niléhn JE. Plasma prothrombin during treatment with Dicumarol. II. Demonstration of an abnormal prothrombin fraction. Scand J Clin Lab Invest. 1968;22(1):23–28. [PubMed]
- Childs B, Der Kaloustian VM. Genetic heterogeneity. N Engl J Med. 1968 Nov 28;279(22):1205–contd. [PubMed]
- Harris H. Enzyme and protein polymorphism in human populations. Br Med Bull. 1969 Jan;25(1):5–13. [PubMed]
- HASSELBACK R, MARION RB, THOMAS JW. Congenital hypofibrinogenemia in five members of a family. Can Med Assoc J. 1963 Jan 5;88:19–22. [PubMed]
- Von Felten A, Duckert F, Frick PG. Familial disturbance of fibrin monomer aggregation. Br J Haematol. 1966 Nov;12(6):667–677. [PubMed]
- Forman WB, Ratnoff OD, Boyer MH. An inherited qualitative abnormality in plasma fibrinogen: fibrinogen Cleveland. J Lab Clin Med. 1968 Sep;72(3):455–472. [PubMed]
- Mammen EF, Prasad AS, Barnhart MI, Au CC. Congenital dysfibrinogenemia: fibrinogen Detroit. J Clin Invest. 1969 Feb;48(2):235–249. [PubMed]
- Egeberg O. Inherited fibrinogen abnormality causing thrombophilia. Thromb Diath Haemorrh. 1967 Feb 28;17(1-2):176–187. [PubMed]
- Blombäck M, Blombäck B, Mammen EF, Prasad AS. Fibrinogen Detroit--a molecular defect in the N-terminal disulphide knot of human fibrinogen? Nature. 1968 Apr 13;218(5137):134–137. [PubMed]
- GOUDEMAND M, FOUCAUT M, HUTIN A, PARQUET-GERNEZ A. LES ANTICOAGULANTS CIRCULANTS ANTI-FACTEUR VIII AU COURS DE L'H'EMOPHILIE A (NATURE ET M'ECANISME D'ACTION.). Nouv Rev Fr Hematol. 1963 Nov–Dec;71:703–722. [PubMed]
- Hoyer LW, Breckenridge RT. Immunologic studies of antihemophilic factor (AHF, factor VIII): cross-reacting material in a genetic variant of hemophilia A. Blood. 1968 Dec;32(6):962–971. [PubMed]
- Feinstein D, Chong MN, Kasper CK, Rapaport SI. Hemophilia A: polymorphism detectable by a factor 8 antibody. Science. 1969 Mar 7;163(871):1071–1072. [PubMed]
- FANTL P, MARR AG, SAWERS RJ. Investigation of a haemorrhagic disease due to beta-prothromboplastin deficiency complicated by a specific inhibitor of thromboplastin formation. Australas Ann Med. 1956 Aug;5(3):163–176. [PubMed]
- Roberts HR, Grizzle JE, McLester WD, Penick GD. Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor. J Clin Invest. 1968 Feb;47(2):360–365. [PubMed]
- Denson KW, Biggs R, Mannucci PM. An investigation of three patients with Christmas disease due to an abnormal type of factor IX. J Clin Pathol. 1968 Mar;21(2):160–165. [PubMed]
- BORCHGREVINK CF, EGEBERG O, POOL JG, SKULASON T, STORMORKEN H, WAALER B. A study of a case of congenital hypoprothrombinaemia. Br J Haematol. 1959 Jul;5:294–301. [PubMed]
- JOSSO F, PROU-WARTELLE O, SOULIER JP. [Study of a case of congenital hypoprothrombinemia.]. Nouv Rev Fr Hematol. 1962 Sep–Oct;2:647–672. [PubMed]
- POOL JG, DESAI R, KROPATKIN M. Severe congenital hypoprothrombinemia in a Negro boy. Thromb Diath Haemorrh. 1962 Nov 15;8:235–240. [PubMed]
- DEBASTOS O, RENO RS, CORREA OT. A STUDY OF THREE CASES OF FAMILIAL CONGENITAL HYPOPROTHROMBINAEMIA (FACTOR II DEFICIENCY). Thromb Diath Haemorrh. 1964 Jul 31;11:497–505. [PubMed]
- Kerr CB. Genetics of human blood coagulation. J Med Genet. 1965 Dec;2(4):254–303. [PubMed]
- Beighton P. X-linked recessive inheritance in the Ehlers-Danlos syndrome. Br Med J. 1968 Aug 17;3(5615):09–11. [PubMed]
|